Bionovate BIIO Stock
Bionovate Price Chart
Bionovate BIIO Financial and Trading Overview
| Bionovate stock price | 0.0001 USD |
| Previous Close | 0.0001 USD |
| Open | 0.0001 USD |
| Bid | 0 USD x 0 |
| Ask | 0 USD x 0 |
| Day's Range | 0.0001 - 0.0001 USD |
| 52 Week Range | 0.0001 - 0.04 USD |
| Volume | 125 USD |
| Avg. Volume | 89 USD |
| Market Cap | 775 USD |
| Beta (5Y Monthly) | 1.089788 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | 0 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
BIIO Valuation Measures
| Enterprise Value | 279.33K USD |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | N/A |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | N/A |
Trading Information
Bionovate Stock Price History
| Beta (5Y Monthly) | 1.089788 |
| 52-Week Change | 0% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 0.04 USD |
| 52 Week Low | 0.0001 USD |
| 50-Day Moving Average | 0.0001 USD |
| 200-Day Moving Average | 0.0001 USD |
BIIO Share Statistics
| Avg. Volume (3 month) | 89 USD |
| Avg. Daily Volume (10-Days) | 12 USD |
| Shares Outstanding | 7.75M |
| Float | 3.95M |
| Short Ratio | N/A |
| % Held by Insiders | 49.00% |
| % Held by Institutions | 0% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 1:100 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | June 30, 2021 |
| Most Recent Quarter (mrq) | September 30, 2021 |
| Next Fiscal Year End | June 30, 2022 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | N/A |
| Return on Equity (ttm) | N/A |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | N/A |
| Net Income Avi to Common (ttm) | -105306 USD |
| Diluted EPS (ttm) | 0 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | N/A |
| Total Cash Per Share (mrq) | N/A |
| Total Debt (mrq) | 278.55K USD |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | N/A |
| Book Value Per Share (mrq) | -0.068 |
Cash Flow Statement
| Operating Cash Flow (ttm) | 0 USD |
| Levered Free Cash Flow (ttm) | N/A |
Profile of Bionovate
| Country | United States |
| State | N/A |
| City | Cham |
| Address | Gewerbestrasse 10 |
| ZIP | 6330 |
| Phone | 41 646 224 1160 |
| Website | https://bionovate.com |
| Industry | Medical Devices |
| Sector(s) | Healthcare |
| Full Time Employees | N/A |
Bionovate Technologies Corp., a medical device company, focuses on developing automated treatment for age spots. It intends to develop automated computerized system that treats age spots anywhere on the body. The company targets to sell its systems to physicians and spas worldwide. The company was formerly known as MJP International Ltd. and changed its name to Bionovate Technologies Corp. in December 2017. Bionovate Technologies Corp. was founded in 2010 and is based in Cham, Switzerland. As of October 7, 2020, Bionovate Technologies Corp. operates as a subsidiary of Human Data AG.
Q&A For Bionovate Stock
What is a current BIIO stock price?
Bionovate BIIO stock price today per share is 0.0001 USD.
How to purchase Bionovate stock?
You can buy BIIO shares on the OTC Markets EXMKT exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Bionovate?
The stock symbol or ticker of Bionovate is BIIO.
Which industry does the Bionovate company belong to?
The Bionovate industry is Medical Devices.
How many shares does Bionovate have in circulation?
The max supply of Bionovate shares is 7.75M.
What is Bionovate Price to Earnings Ratio (PE Ratio)?
Bionovate PE Ratio is now.
What was Bionovate earnings per share over the trailing 12 months (TTM)?
Bionovate EPS is 0 USD over the trailing 12 months.
Which sector does the Bionovate company belong to?
The Bionovate sector is Healthcare.